Percutaneous mechanical thrombectomy for acute massive lower extremity XXXX .

@entity1 @entity1150 @entity2979 @entity1151
PURPOSE: To evaluate the clinical safety and effectiveness of percutaneous mechanical thrombectomy in @entity1 with acute massive lower extremity @entity1150 . MATERIALS AND METHODS: Twenty-five consecutive @entity1 with acute massive lower extremity @entity1150 were included in this retrospective study. An inferior vena cava filter was placed prophylactically to protect against @entity1151 in each @entity1 . Percutaneous mechanical thrombectomy was performed using a 7F Amplatz thrombectomy device in an angiography suite through ipsilateral popliteal vein access. Anticoagulant therapy lasted for at least 6 months. Follow-up data included 1 year's color duplex sonography and clinical interviews. RESULTS: Successful placement of an inferior vena cava filter was achieved in all 25 (100%) @entity1 . Twenty-two @entity1 (88%) were clinically asymptomatic within 24 hours, whereas the remaining 3 @entity1 (12%) showed moderate improvement within 48 hours. Venogram at discharge showed grade III lysis in 23 @entity1 (92%) and grade II lysis in 2 @entity1 (8%). No serious complications were reported during hospitalization in this study. At 1-year follow-up, no recurrent @entity1150 was reported; 1 @entity1 developed a mild @entity2979 . CONCLUSION: Percutaneous mechanical thrombectomy is a safe and effective treatment for acute massive lower extremity @entity1150 and shows promising clinical mid-term results.
